ABSTRACT
It is assumed that 25 percent of patients with epilepsy are women of fertile age and 0.3 percent to 0.6 percent of all children are born of mothers with epilepsy. The aim of this study was to evaluate the quality of life on pregnant with epilepsy and compare with non-pregnant women with epilepsy. We evaluated two groups (Experimental Group - 29 pregnant women with epilepsy and Control Group - 30 women with epilepsy); they were attended at the HC/UNICAMP. The patients had three meetings to carry out and implement the anamnesis and the application of QQV-65. There were no significant differences in the measurement of quality of life when comparing both groups. However, when we analyzed individually in the pre- and post-partum periods, we observed significant differences in health aspects (p=0.0495), physical (p=0.02868) and emotional (p=0.0253) dimensions in QQV-65. This study shows that pregnancy could be interpreted as a stressor. In late pregnancy when this stressor was removed, women with epilepsy had improvement in their quality of life.
Admite-se que 25 por cento dos pacientes com epilepsia sejam mulheres em idade fértil e que 0,3 por cento a 0,6 por cento de todas as crianças nascidas sejam filhas de mães epilépticas. O objetivo do presente estudo foi avaliar a qualidade de vida em gestantes com epilepsia e compará-la com a de mulheres com epilepsia não grávidas. Foram avaliados dois grupos (Grupo Experimental - 29 gestantes com epilepsia e Grupo Controle - 30 mulheres com epilepsia) atendidos no HC/UNICAMP. As pacientes foram submetidas a três encontros para a realização de anamnese e a aplicação do QQV-65. Não encontramos diferenças significativas na avaliação de qualidade de vida ao comparar ambos os grupos. No entanto quando avaliados individualmente no período pré e pós-natal, observamos diferenças significativas nos aspectos: saúde (p=0,0495), físico (p=0,02868) e emocional (p=0,0253) no QQV-65. Este estudo mostrou que a gravidez pode ser interpretada como um estressor. No final da gravidez, quando este estressor foi removido, mulheres com epilepsia mostraram melhora na qualidade de vida.
Subject(s)
Adolescent , Adult , Female , Humans , Pregnancy , Young Adult , Epilepsy/psychology , Pregnancy Complications/psychology , Quality of Life/psychology , Case-Control Studies , Socioeconomic Factors , Surveys and QuestionnairesABSTRACT
We conducted an open, add-on study with topiramate (TPM) as adjunctive therapy in Lennox-Gastaut syndrome (LGS), to assess the long-term efficacy and safety and to evaluate quality of life (QL) measurements in the chronic use of TPM. We studied 19 patients (11 male; age ranging from 4 to 14 years) with uncontrolled seizures receiving 2-3 anti- epileptic drugs. Patients were followed up to 36 months of treatment. A questionnaire was used to query parents about QL. Seven patients completed the study at 36 months and seizure frequency was reduced = 75 per cent in 4, and < 50 per cent in patients. Two children became seizure free for more than 24 months. Most side effects were CNS related, with the most frequent being somnolence and anorexia. These were generally transient. One patient dropped-out due to powder in the urine. None of the patients required hospitalization. At 36 months, patients' alertness (2/7), interaction with environment (5/7), ability to perform daily activities (5/7), and verbal performance (6/7) improved on TPM. We conclude that TPM may be useful as adjunctive therapy in the treatment of LGS. The efficacy of TPM was maintained in long-term treatment in more than 40 per cent of patients, long term safety was confirmed and QL improve on TPM.
Subject(s)
Female , Humans , Adolescent , Child, Preschool , Child , Anticonvulsants/therapeutic use , Epilepsy/drug therapy , Fructose/analogs & derivatives , Fructose/therapeutic use , Anticonvulsants/pharmacokinetics , Follow-Up Studies , Fructose/pharmacokinetics , Treatment OutcomeABSTRACT
O objetivo deste trabalho foi investigar se as mulheres com epilepsia parciais secudariamente generalizadas exibem mais ansiedade com estado e traço, durante o período pré-mentrual do que em outros períodos do mês, em comparaçäo com outras mulheres näo epilépticas, através do uso do inventário de ansiedade traço e estado de Spielperger, Gorsuch e Luschene (1970). A presença de ansiedade-estado medida nas condiçöes pré e pós-mentrual näo diferenciou os dois grupos estudados, epilépticas e näo epilépticas. A presença de ansiedade apareceu independente das fases do ciclo menstrual. No entanto, verificou-se a presença da ansiedade-traço em algumas mulheres epilépticas, sugerindo talvez, a ansiedade como característica de personalidade